- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Mark D. Polston
Events 27 results
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Webinar
April 29, 2021
Protecting Your CARES Act Provider Relief Funds During Audit and Enforcement: The Time to Act Is Now
Webinar
January 19, 2021
Rounding Out 2020: Overview of Recent Statutory and Regulatory Changes to Medicare and Medicaid Reimbursement
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Webinar
April 24, 2020
Compliance Issues Related to Receipt of CARES Act Funding, plus Latest Congressional and CMS Actions Related to COVID-19
Webinar
April 3, 2020
Latest Congressional and CMS Actions Related to COVID-19
Webinar
March 27, 2020
Impact of Congressional Actions Related to COVID-19 on Healthcare Providers
Webinar
March 19, 2020
Impact of CMS’s Section 1135 Waiver on Hospital Operations and Reimbursement During the Coronavirus Pandemic
Webinar
January 22, 2020
A Review of the Practical and Legal Challenges Posed by CMS’s New Hospital Price Transparency Rule
Webinar
August 21, 2019
Medicare Litigation Opportunities after Allina and Kisor
Speaking Engagement
June 18, 2019
Mark Polston to Speak at HFMA Greater Heartland Conference About Medicare Cost Report Appeals